Details for New Drug Application (NDA): 203062
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 203062
| Tradename: | RIZATRIPTAN BENZOATE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | rizatriptan benzoate |
| Patents: | 0 |
Pharmacology for NDA: 203062
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203062
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203062 | ANDA | Golden State Medical Supply, Inc. | 51407-679 | 51407-679-03 | 1 BLISTER PACK in 1 CARTON (51407-679-03) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51407-679-11) |
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203062 | ANDA | Golden State Medical Supply, Inc. | 51407-679 | 51407-679-18 | 3 BLISTER PACK in 1 CARTON (51407-679-18) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51407-679-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Jul 1, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Jul 1, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
